AU2003290279A1 - Quinazoline derivatives - Google Patents

Quinazoline derivatives

Info

Publication number
AU2003290279A1
AU2003290279A1 AU2003290279A AU2003290279A AU2003290279A1 AU 2003290279 A1 AU2003290279 A1 AU 2003290279A1 AU 2003290279 A AU2003290279 A AU 2003290279A AU 2003290279 A AU2003290279 A AU 2003290279A AU 2003290279 A1 AU2003290279 A1 AU 2003290279A1
Authority
AU
Australia
Prior art keywords
quinazoline derivatives
quinazoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290279A
Inventor
Bernard Barlaam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2003290279A1 publication Critical patent/AU2003290279A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2003290279A 2002-12-23 2003-12-18 Quinazoline derivatives Abandoned AU2003290279A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02293221.4 2002-12-23
EP02293221 2002-12-23
PCT/GB2003/005540 WO2004056801A1 (en) 2002-12-23 2003-12-18 Quinazoline derivatives

Publications (1)

Publication Number Publication Date
AU2003290279A1 true AU2003290279A1 (en) 2004-07-14

Family

ID=32668915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290279A Abandoned AU2003290279A1 (en) 2002-12-23 2003-12-18 Quinazoline derivatives

Country Status (2)

Country Link
AU (1) AU2003290279A1 (en)
WO (1) WO2004056801A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ598516A (en) 2009-09-03 2013-02-22 Bristol Myers Squibb Co Quinazolines as potassium ion channel inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
GB9922171D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
UA73993C2 (en) * 2000-06-06 2005-10-17 Астразенека Аб Quinazoline derivatives for the treatment of tumours and a pharmaceutical composition
WO2002092577A1 (en) * 2001-05-14 2002-11-21 Astrazeneca Ab Quinazoline derivatives
WO2002092579A1 (en) * 2001-05-14 2002-11-21 Astrazeneca Ab 4-anilinoquinazoline derivatives
WO2002092578A1 (en) * 2001-05-14 2002-11-21 Astrazeneca Ab Quinazoline derivatives

Also Published As

Publication number Publication date
WO2004056801A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
HK1111417A1 (en) Quinazoline derivatives
GB0215823D0 (en) Quinazoline derivatives
AUPR975601A0 (en) Quinazolinone derivatives
AU2002352444A1 (en) Quinazolinedione derivatives
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003287992A1 (en) Cyclohexylurea derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
GB2410025B (en) Quinazolin-4-one derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003263323A1 (en) Quinazolinone derivatives
PL374817A1 (en) Quinazoline derivatives
AU2003255803A1 (en) Quinazolinone derivatives
AU2003238180A1 (en) 2-naphtamide derivatives
AU2002249639A1 (en) Pyranocoumarin derivatives
AU2003273398A1 (en) Aroyl-piperidine derivatives
AU2002368112A1 (en) Pyrimidine derivatives
AU2003288012A1 (en) Isothiazolyl-benzoxazine derivatives
AU2003243397A1 (en) Homo-camptothecin derivatives
AU2003284704A1 (en) Substituted 1h-pyridine-2-one derivatives
AU2003290279A1 (en) Quinazoline derivatives
AU2003217800A1 (en) Synthetic derivatives
AU2002302736A1 (en) Quinazoline derivatives
AU2002249413A1 (en) Quinazoline derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase